CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
109 hedge funds and large institutions have $1.43B invested in Clovis Oncology, Inc. in 2013 Q2 according to their latest regulatory filings, with 109 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+109
Holders Change %
–
% of All Funds
3.56%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.16%
New
109
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Barclays
London,
United Kingdom
| $128K | +$128K | +1,914 | New |
|
102
Bessemer Group
Woodbridge,
New Jersey
| $90K | +$90K | +1,350 | New |
|
|
TRCT
103
Tower Research Capital (TRC)
New York
| $77K | +$77K | +1,150 | New |
|
104
Ameriprise
Minneapolis,
Minnesota
| $60K | +$60K | +901 | New |
|
105
Citigroup
New York
| $21K | +$21K | +318 | New |
|
106
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $17K | +$17K | +250 | New |
|
107
Loomis, Sayles & Company
Boston,
Massachusetts
| $11.4K | +$11.4K | +170,483 | New |
|
|
PMFA
108
Plante Moran Financial Advisors
Southfield,
Michigan
| $4K | +$4K | +57 | New |
|
|
EFSCE
109
Enterprise Financial Services Corp (EFSC)
Clayton,
Missouri
| $4K | +$4K | +64 | New |
|